Scibase is the developer and producer of Nevisence, the first-ever clinical tool to diagnose skin disorders using electrical impedance spectrometry (EIS). Nevisense is FDA-approved and CE-marked for skin cancer detection and is published in over 80 research projects globally across a range of skin disorders.

Scibase